Table 1.

Baseline characteristics of study participants

Characteristics
Age (y), median (range)71 (46-92)
Baseline PSA (ng/dL), median (range)75.1 (6.3-10,181)
Performance status, n (%)
    019 (36)
    128 (53)
    26 (11)
Measurable disease, n (%)48 (91)
Prior taxane therapy, n (%)53 (100)
Race, n (%)
    White49 (92)
    Other4 (8)